CIK 0000899460
- Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133607736
- Phone
- +1 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- 4 Grant or award Chief Financial Officer acquired 92,000 shares (grant or award)
- 4 Grant or award Chief People & Workpl Officer acquired 92,000 shares (grant or award)
- 4 Grant or award EVP Chief Medical Officer acquired 210,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP Genl Counsel & Secretary sold 95,576 shares at $4.68 ($447,754)
- 4 Grant or award Chief People & Workpl Officer acquired 400,000 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 150,000 shares at $4.69 ($702,780)
- 4 Open-market sale Chief Financial Officer sold 47,810 shares at $4.68 ($223,512)
- 4 Grant or award EVP Chief Operating Officer acquired 210,000 shares (grant or award)
- 4 Shares withheld for taxes EVP Genl Counsel & Secretary gave up 6,001 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People & Workpl Officer gave up 5,941 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 16,434 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,972 shares (to pay taxes)
- 4 Grant or award EVP Chief Operating Officer acquired 14,184 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 11,820 shares (grant or award)
Page 9 of 50 · 998 filings